Drug
Zelicapavir
Zelicapavir: highest development phase Phase 2/3, developed by Enanta Pharmaceuticals. 3 trial records tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Enanta Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| zelicapavir NCT07908381 | Phase 2/3 | RSV |
| zelicapavir NCT07482657 | Phase 2 | RSV Infection |
| zelicapavir (therapeutic dose) NCT06601192 | Phase 1 | RSV Infection |
Latest
No recent events.
Follow Zelicapavir on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.